Procedure market
China Hair Transplant Market Outlook 2026
China's hair transplant market reached USD 3.1 billion in 2025 with a 14.2% CAGR through 2030, propelled by Gen-Z and millennial demand, FUE/DHI capacity expansion and aggressive brand consolidation.
Market size (2025)
USD 3.10 billion
CAGR
14.2%
Forecast (2030)
USD 5.98 billion
Geography
Mainland China (private hair restoration chains and hospital-based programmes)
International-patient cost band
$2,200–$6,800 USD
Market size, 2021–2030
Mainland China (private hair restoration chains and hospital-based programmes).
| Year | Market size (USD) | Status |
|---|---|---|
| 2021 | USD 1.38 billion | Historical |
| 2022 | USD 1.72 billion | Historical |
| 2023 | USD 2.15 billion | Historical |
| 2024 | USD 2.62 billion | Historical |
| 2025 | USD 3.10 billion | Latest actual |
| 2026 | USD 3.54 billion | Forecast |
| 2030 | USD 5.98 billion | Forecast |
Demand drivers
- Androgenetic alopecia prevalence: ~250 million Chinese adults with self-reported hair loss.
- Social-media-led demand from men aged 22–38; female hair-line lowering as fastest-growing female segment.
- Price compression: average per-graft price fell from RMB 18–25 in 2019 to RMB 8–14 in 2025.
- Insurance-style instalment financing (Huabei, Bairong) lowered upfront cash barriers.
Supply-side landscape
- Five national chains hold ~55% of branded market: Yonghe Medical, Carenel (科发源), New Hair (新生), Bosley China, Da Mai.
- Hospital-based programmes (Class A dermatology departments) hold the premium segment for international patients.
- DHI Choi-implanter and sapphire-blade FUE replaced strip-FUT in >95% of premium-tier clinics.
Risks & headwinds
- Quality dispersion: graft survival highly operator-dependent.
- Regulatory tightening on advertising claims under NHC 2024 cosmetic-medicine rules.
- Mid-tier chains face margin pressure as per-graft pricing keeps falling.
Notable providers
Provider
Yonghe Medical (HK:2279)
Largest listed hair restoration chain in China; 60+ city footprint.
Provider
Carenel / 科发源
Premium positioning with surgeon-led DHI.
Provider
Class A dermatology programmes
PUMCH, Huashan, Sun Yat-sen Memorial — hospital-grade FUE/DHI for international patients.
Frequently asked
- How big is the China hair transplant market in 2026?
- USD 3.1 billion in 2025 with a forecast to USD 3.54 billion in 2026 and USD 5.98 billion by 2030 — a 14.2% CAGR, the fastest-growing aesthetic medicine segment in China.
- What does FUE hair transplant cost in China for international patients?
- USD 2,200–6,800 all-in for 2,500–4,500 grafts at a Class A dermatology department, including pre-op workup, the procedure, post-op medication and a 12-month follow-up programme.
- Who are the leading hair transplant providers in China?
- Yonghe Medical, Carenel and New Hair lead the chain market; Class A hospital dermatology departments (PUMCH, Huashan, Sun Yat-sen Memorial) lead the international-patient premium segment.
Sources
- Yonghe Medical (HK:2279) FY2024 annual report
- China Insights Consultancy Aesthetic Medicine Market Report 2025
- Partner-network 2026 international-patient quote data
- National Health Commission cosmetic-medicine regulatory framework 2024
Last reviewed: 2026-05-12.
Going beyond the report
For a written quote from two Class A international departments — covering procedure, hospital match, recovery and visa — start the quote wizard.